The Arg16Gly-β2-adrenoceptor single nucleotide polymorphism: Exercise capacity and survival in patients with end-stage heart failure

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 382, Issue 4, 2010, Pages 357-365

  Leineweber, Kirsten ^a   Frey, Ulrich H ^a   Tenderich, Gero ^b   Toliat, Mohammad Reza ^c   Zittermann, Armin ^b   Nürnberg, Peter ^c   Körfer, Reiner ^b   Siffert, Winfried ^a   Heusch, Gerd ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

1 adrenoceptor polymorphisms; 2 adrenoceptor polymorphisms; Exercise; Heart failure; Mortality; Prognosis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; DIASTOLIC BLOOD PRESSURE; EXERCISE; FATALITY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENOTYPE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE;

BLOOD PRESSURE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; GENOTYPE; HEART FAILURE; HEART RATE; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PHYSICAL EXERTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; TREATMENT OUTCOME;

EID: 77957575139     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0548-z     Document Type: Article

References (58)

1. A Biolo N Clausell KG Santos R Salvaro P Ashton-Prolla A Borges LE Rohde 2008 Impact of β1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy Am J Cardiol 102 726 732 10.1016/j.amjcard.2008.04.070 18773997 1:CAS:528:DC%2BD1cXhtVygurzI
2. 1-adrenergic receptor associated with survival in patients with heart failure Eur Heart J 21 1853 1858 10.1053/euhj.1999.1994 11052857
3. 2-adrenoceptors in the human heart: properties, function, and alterations in heart failure Pharmacol Rev 43 203 242 1677200 1:CAS:528:DyaK3MXmtVClsbk%3D
4. O-E Brodde 2008 Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses Pharmacol Ther 117 1 29 10.1016/j.pharmthera.2007.07.002 17916379 1:CAS:528:DC%2BD2sXhsVSmtLzL (Pubitemid 350193335)
5. O-E Brodde K Leineweber 2004 Autonomic receptor systems in the failing and aging human heart: similarities and differences Eur J Pharmacol 500 167 176 10.1016/j.ejphar.2004.07.022 15464030 1:CAS:528:DC%2BD2cXotFClurc%3D (Pubitemid 39304006)
6. O-E Brodde MC Michel 1999 Adrenergic and muscarinic receptors in the human heart Pharmacol Rev 51 651 689 10581327 1:CAS:528:DC%2BD3cXnslChsLs%3D
7. O-E Brodde H Bruck K Leineweber T Seyfarth 2001 Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart Basic Res Cardiol 96 528 538 10.1007/s003950170003 11770070 1:CAS:528:DC%2BD38Xhs12qsw%3D%3D (Pubitemid 33121025)
8. 1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity J Am Coll Cardiol 46 2111 2115 10.1016/j.jacc.2005.08.041 16325050 1:CAS:528:DC%2BD2MXht1Onur7K (Pubitemid 41713600)
9. 2-adrenergic receptor gene haplotypes and venodilation in vivo Clin Pharmacol Ther 78 232 238 10.1016/j.clpt.2005.06.002 16153394 1:CAS:528:DC%2BD2MXpvV2rtrY%3D (Pubitemid 41254108)
10. 1-adrenoceptor polymorphism in humans Pharmacogenetics 11 199 205 10.1097/00008571-200104000- 00003 11337935 (Pubitemid 32319869)
11. RM Canham SR Das D Leonard SM Abdullah SK Mehta AK Chung JL Li RG Victor RJ Auchus MH Drazner 2007 Alpha2cDel322-325 and beta1Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume J Am Coll Cardiol 49 274 276 10.1016/j.jacc.2006.10.016 17222742 1:CAS:528:DC%2BD2sXmtVCrsA%3D%3D (Pubitemid 46054397)
12. 2-Adrenoceptor polymorphism determines vascular reactivity in humans Hypertension 36 371 375
13. P De Groote N Lamblin N Helbecque F Mouquet E McFadden X Hermant P Amouyel J Dallongeville C Bauters 2005 The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure Eur J Heart Fail 7 966 973 10.1016/j.ejheart.2004.10.006 16227135 1:CAS:528: DC%2BD2MXhtFShs77M (Pubitemid 41443589)
14. 1- adrenoceptor gene and aerobic power in coronary artery disease Eur Heart J 27 808 816 10.1093/eurheartj/ehi737 16421173 1:CAS:528:DC%2BD28XjvFOntLo%3D
15. V Dishy GG Sofowora HG Xie RB Kim DW Byrne CM Stein AJ Wood 2001 The effect of common polymorphisms of the β2-adrenergic receptor on agonist-mediated vascular desensitization N Engl J Med 345 1030 1035 10.1056/NEJMoa010819 11586955 1:CAS:528:DC%2BD3MXntlehsb8%3D
16. JH Eisenach SA Barnes TL Pike LA Sokolnicki S Masuki NM Dietz KH Rehfeldt ST Turner MJ Joyner 2005 Arg16/Gly beta2-adrenergic receptor polymorphism alters the cardiac output response to isometric exercise J Appl Physiol 99 1776 1781 10.1152/japplphysiol.00469.2005 15994241 1:CAS:528:DC%2BD2MXht1CrtbbL (Pubitemid 41547174)
17. DS Feldman CA Carnes WT Abraham MR Bristow 2005 Mechanisms of disease: beta-adrenergic receptors-alterations in signal transduction and pharmacogenomics in heart failure Nat Clin Pract Cardiovasc Med 2 475 483 10.1038/ncpcardio0309 16265588 1:CAS:528:DC%2BD2MXhtVGnurvF (Pubitemid 41223525)
18. M Flesch E Erdmann M Böhm 1996 Changes in beta-adrenoceptors and G-proteins during the transition from cardiac hypertrophy to heart failure J Card Fail 2 S35 S43 10.1016/S1071-9164(96)80057-1 8951559 1:STN:280: DyaK2s7gvFakuw%3D%3D
19. C Forleo N Resta S Sorrentino P Guida A Manghisi V De Luca R Romito M Iacoviello E De Tommasi F Troisi B Rizzon G Guanti P Rizzon MV Pitzalis 2004 Association of β-adrenergic receptor polymorphisms and progression of heart failure in patients with idiopathic dilated cardiomyopathy Am J Med 117 451 458 10.1016/j.amjmed.2004.04.012 15464701 1:CAS:528:DC%2BD2cXotFCmsbk%3D (Pubitemid 39349582)
20. 2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans J Physiol 546 2 583 589 10.1113/jphysiol.2002.031138 12527744 1:CAS:528:DC%2BD3sXitVWqsrk%3D (Pubitemid 36175993)
21. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor J Biol Chem 268 23116 23121 7901205 1:CAS:528:DyaK3sXlslCgsL0%3D
22. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties Biochemistry 33 9414 9419 10.1021/bi00198a006 7915137 1:CAS:528:DyaK2cXltVSnsbw%3D
23. s Eur J Pharmacol 421 141 147 10.1016/S0014-2999(01)01049-4 11516429 1:CAS:528:DC%2BD3MXksVGru7k%3D (Pubitemid 32539414)
24. 1-adrenoceptors Br J Pharmacol 142 51 56 10.1038/sj.bjp.0705753 15037517 1:CAS:528:DC%2BD2cXktFyqtb8%3D (Pubitemid 38698193)
25. 1-adrenoceptor gene polymorphism determines contractile response to catecholamines Pharmacogenetics 14 711 716 10.1097/00008571-200411000-00001 1:CAS:528:DC%2BD2cXhtVais7%2FP (Pubitemid 39552785)
26. 2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes Life Sci 74 2803 2814 10.1016/j.lfs.2003.10.025 15072081 1:CAS:528:DC%2BD2cXisF2ms74%3D (Pubitemid 38402097)
27. 2- Adrenoceptor polymorphisms and cardiovascular diseases Br J Pharmacol 158 61 69 10.1111/j.1476-5381.2009.00187.x 19422376 1:CAS:528:DC%2BD1MXhsVKmu7bM
28. K Leineweber R Büscher H Bruck O-E Brodde 2004 β-Adrenoceptor polymorphisms Naunyn-Schmiedeberg's Arch Pharmacol 369 1 22 10.1007/s00210-003- 0824-2 1:CAS:528:DC%2BD2cXitF2htg%3D%3D (Pubitemid 38161220)
29. 1-adrenoceptor polymorphism does not affect cardiac effects of exercise after parasympathetic inhibition by atropine Pharmacogenet Genomics 16 9 13 10.1097/01.fpc.0000184956.16077.93 16344717 1:CAS:528:DC%2BD2MXhtlShtr7L
30. 1-adrenoceptor polymorphism Naunyn-Schmiedeberg's Arch Pharmacol 375 303 309 10.1007/s00210-007-0166-6 1:CAS:528:DC%2BD2sXmsFKitr0%3D (Pubitemid 46945336)
31. 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation J Biol Chem 277 30429 30435 10.1074/jbc.M200681200 12034720 1:CAS:528:DC%2BD38XmsFyqsb8%3D (Pubitemid 34970733)
32. 1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure Proc Natl Acad Sci USA 103 11288 11293 10.1073/pnas.0509937103 16844790 1:CAS:528: DC%2BD28XnvValtbc%3D (Pubitemid 44156511)
33. 1-adrenoceptor is associated with the cardiovascular response to metoprolol Clin Pharmacol Ther 74 372 379 10.1016/S0009-9236(03)00224-8 14534524 1:CAS:528:DC%2BD3sXnvVyks74%3D (Pubitemid 37222858)
34. MJ Lohse S Engelhardt S Danner M Böhm 1996 Mechanisms of beta-adrenergic receptor desensitization: from molecular biology to heart failure Basic Res Cardiol 91 suppl 2 29 34 10.1007/BF00795359 8957541 1:CAS:528:DyaK2sXlslaq
35. MJ Lohse S Engelhardt T Eschenhagen 2003 What is the role of beta-adrenergic signaling in heart failure? Circ Res 93 896 906 10.1161/01.RES.0000102042.83024.CA 14615493 1:CAS:528:DC%2BD3sXoslykurk%3D (Pubitemid 37433227)
36. 1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy Clin Pharmacol Ther 78 221 231 10.1016/j.clpt.2005.06.004 16153393 1:CAS:528:DC%2BD2MXpvV2rtrk%3D (Pubitemid 41254107)
37. 1- adrenergic receptor J Biol Chem 274 12670 12674 10.1074/jbc.274.18.12670 10212248 1:CAS:528:DyaK1MXjtFGnsrk%3D (Pubitemid 29215505)
38. 1-Adrenergic receptor polymorphisms confer differential function and predisposition to heart failure Nat Med 9 1300 1305 10.1038/nm930 14502278 1:CAS:528:DC%2BD3sXns1Clu7s%3D (Pubitemid 37279854)
39. 1-adrenergic receptor polymorphisms in human right atrium in vitro J Am Coll Cardiol 40 1275 1282 10.1016/S0735-1097(02)02137-X 12383575 1:CAS:528:DC%2BD38Xot1Wgsb4%3D
40. A Muthumula F Drenos PM Elliott SE Humphries 2008 Role of β adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis Eur J Heart Fail 10 3 13 10.1016/j.ejheart.2007.11.008 1:CAS:528:DC%2BD1cXisl2jsA%3D%3D
41. J Myers M Prakash V Froelicher D Do S Partington JE Atwood 2002 Exercise capacity and mortality among men referred for exercise testing N Engl J Med 346 793 801 10.1056/NEJMoa011858 11893790 (Pubitemid 34987553)
42. 1-adrenoceptor and α-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study J Appl Physiol 100 507 511 10.1152/japplphysiol.00899.2005 16210433 1:CAS:528:DC%2BD28Xhs1Khu78%3D (Pubitemid 43671601)
43. 1-adrenergic receptor affect agonist-promoted trafficking J Cardiovasc Pharmacol 39 155 160 10.1097/00005344-200202000-00001 11791000 1:CAS:528:DC%2BD38XosFKnsw%3D%3D (Pubitemid 34093534)
44. 2-adrenergic receptor signaling J Biol Chem 278 10784 10789 10.1074/jbc.M206054200 12525504 1:CAS:528: DC%2BD3sXitVCqtL8%3D (Pubitemid 36800351)
45. 1-adrenergic receptor gene polymorphism and human fat cell lipolysis Int J Obes 25 1599 1603 10.1038/sj.ijo.0801815 1:CAS:528: DC%2BD3MXptVKlurs%3D (Pubitemid 33052066)
46. 1-adrenoceptors in isolated human atrial myocardium Br J Pharmacol 138 386 392 10.1038/sj.bjp.0705030 12540530 1:CAS:528:DC%2BD3sXhtlSitr0%3D (Pubitemid 36188600)
47. 1-adrenoceptor Naunyn-Schmiedeberg's Arch Pharmacol 367 10 21 10.1007/s00210-002-0652-9 1:CAS:528:DC%2BD3sXlvV2kug%3D%3D (Pubitemid 36207676)
48. Savva J, Maqbool A, White HL, Galloway SL, Yuldasheva NY, Ball SG, West RM, De Boer RA, Van Veldhuisen DJ, Balmforth AJ; On behalf of the MERIT-HF study group 2009 Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy J Card Fail 15 435 441 10.1016/j.cardfail.2008.12.005 1:CAS:528:DC%2BD1MXms1ygs74%3D
49. AJ Sehnert SE Daniels M Elashoff JA Wingrove CR Burrow B Horne JB Muhlestein M Donahue SB Liggett JL Anderson WE Kraus 2008 Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol J Am Coll Cardiol 52 644 651 10.1016/j.jacc.2008.05.022 18702968 1:CAS:528:DC%2BD1cXpvFGgt7c%3D
50. 2- adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure Am J Cardiol 99 250 255 10.1016/j.amjcard.2006.08.020 17223428 1:CAS:528:DC%2BD2sXmtVGitg%3D%3D (Pubitemid 46072763)
51. EM Snyder ST Turner BD Johnson 2006 Beta2-adrenergic receptor genotype and pulmonary function in patients with heart failure Chest 130 1527 1534 10.1378/chest.130.5.1527 17099033 (Pubitemid 44786749)
52. 1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β-blockade Clin Pharmacol Ther 73 366 371 10.1016/S0009-9236(02)17734-4 12709726 1:CAS:528:DC%2BD3sXjtFWntbo%3D (Pubitemid 36403596)
53. DY Sue K Wasserman RB Moricca R Casaburi 1988 Metabolic acidosis during exercise in patients with chronic obstructive pulmonary disease. Use of the V-slope method for anaerobic threshold determination Chest 94 931 938 10.1378/chest.94.5.931 3180897 1:STN:280:DyaL1M%2FjtVSgsA%3D%3D
54. DR Taylor 2007 β-Adrenergic receptor polymorphism: relationship to the β-agonist controversy and clinical implication Expert Opin Pharmacother 8 3195 3203 10.1517/14656566.8.18.3195 18035963 1:CAS:528:DC%2BD2sXhtlCltr3O
55. sα fusion proteins Recept Channels 9 315 323 14527875 1:CAS:528:DC%2BD3sXnvVOlt78%3D (Pubitemid 37369343)
56. HL White RA de Boer A Maqbool D Greenwood DJ van Veldhuisen R Cuthbert SG Ball AS Hall AJ Balmforth MERIT-HF Study Group 2003 An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study Eur J Heart Fail 5 463 468 10.1016/S1388-9842(03)00044-8 12921807 1:CAS:528:DC%2BD3sXmt1Kitb4%3D (Pubitemid 37021640)
57. R Wolk EM Snyder VK Somers ST Turner LJ Olson BD Johnson 2007 Arginine 16 glycine beta2-adrenoceptor polymorphism and cardiovascular structure and function in patients with heart failure J Am Soc Echocardiogr 20 290 297 10.1016/j.echo.2006.08.011 17336757
58. 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo Pharmacogenetics 11 191 197 10.1097/00008571-200104000- 00002 11337934 1:CAS:528:DC%2BD3MXjs1Sru7s%3D (Pubitemid 32319868)